Wilmington, Delaware, United States, June 17, 2023 (GLOBE NEWSWIRE) The global paclitaxel injection market stood at US$ 811.0 million in 2022, and the global market is projected to reach US$ 484.5 million by 2031.
Amid an ongoing drug shortage, the FDA is allowing the chemotherapy drug cisplatin to be imported from China. The Chinese manufacturer Qilu Pharmaceutical Co., Ltd., alongside its distributor Apotex Corp., is coordinating with the FDA to increase the availability of cisplatin 50 mg/50 mL (1 mg/mL) vials, the FDA said. The treatment will be available for ordering on June 6.